Assembly Biosciences (ASMB) Other Operating Expenses (2016 - 2021)

Assembly Biosciences' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $41.6 million for Q4 2021.

• In Q4 2021, Other Operating Expenses changed N/A year-over-year to $41.6 million; the TTM figure through Sep 2022 stood at $41.6 million (changed N/A YoY), while the FY2021 annual figure was $41.6 million, changed N/A from the prior year.
• Other Operating Expenses for Q4 2021 stood at $41.6 million, up from $4000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $41.6 million in Q4 2021, with the low at -$127000.0 in Q2 2018.
• The 4-year median for Other Operating Expenses is $4.5 (2017), against an average of $4.1 million.
• The sharpest annual moves came in 2018 and 2019: Other Operating Expenses slumped 39713.53% in 2018, then surged 104.35% in 2019.
• Assembly Biosciences' Other Operating Expenses stood at -$447.0 in 2017, then tumbled by 18244.52% to -$82000.0 in 2018, then surged by 104.88% to $4000.0 in 2019, then surged by 1040850.0% to $41.6 million in 2021.
• Business Quant data shows ASMB's Other Operating Expenses at $41.6 million in Q4 2021, $4000.0 in Q2 2019, and $1000.0 in Q1 2019.